HPV vaccine is an issue of great concern to the public, and HPV vaccine is also an important primary preventive measure for cervical cancer prevention and control measures. On May 30, the National Health and Health Commission held a press conference. At the meeting, Wang Linhong, chairman of the Women’s Health Branch of the Chinese Preventive Medicine Association and chief expert on chronic diseases of the Chinese Center for Disease Control and Prevention, said that on the whole, the current HPV vaccine is still in short supply. The number of school-age women is relatively large, so the HPV vaccination rate is relatively low. Wang Linhong emphasized that in this case, there is no need to miss the best vaccination time because of waiting for a higher-priced vaccine. The next step is to promote the free HPV vaccination policy to cover more people.
▲Chairman of Women’s Health Branch of Chinese Preventive Medicine Association, Chief of Chronic Diseases of China CDC Expert Wang Linhong
It is reported that five HPV vaccines have been approved for registration in my country, including three imported HPV vaccines and two domestic vaccines. Data from the National Routine Vaccine Statement shows that from 2018 to 2020, the number of HPV vaccinations has increased year by year, from 3.417 million in 2018 to 12.279 million in 2020.
Wang Linhong said that in recent years, the country has been actively strengthening the scientific publicity of HPV vaccination and promoting the pilot work of HPV vaccine. In accordance with the work idea of overall advancement and key breakthroughs, the three provinces of Guangdong, Hainan and Fujian have been promoted to start the implementation of free domestic bivalent vaccines for school-age girls in the province. project. Other cities have also used the platform of Healthy City to promote the pilot work of comprehensive cervical cancer prevention and control. Pilot cities such as Jinan, Xiamen, Wuxi, and Ordos have introduced free HPV vaccination policies for school-age girls. Chengdu has given school-age girls the HPV vaccine. Fixed subsidy. A recent summary of data shows that the HPV vaccination coverage of junior high school girls in these pilot areas has been greatly improved, and in some cities it has reached more than 90%.
Wang Linhong said that in the next step, the pilots will be summarized to promote the free HPV vaccination policy to cover more people.
Wang Linhong also made a special science popularization for some people who are waiting for high-priced vaccines. At present, the HPV vaccines available in our country include bivalent vaccine, quadrivalent vaccine and nine-valent vaccine, which are used in women aged 9-45 years, but the high-risk HPV types that cause cervical cancer are mainly subtypes 16 and 18, so Bivalent vaccines can prevent more than 70% of cervical cancers. Another important point is that the HPV vaccine has the best protection effect for adolescent girls who have not yet been infected with the virus, so the World Health Organization recommends girls aged 9 to 14 as the primary vaccination group, and the earlier the vaccination, the better the effect. Therefore, under the current situation of tight supply of HPV vaccines, there is no need to miss the best vaccination time because of waiting for higher-priced vaccines.
Red Star News reporter Wu Yang Intern reporter Hu Yiwen Beijing report
Editor Guan Li